Correction to: Oncogene (2013) 32, 5359-5368; doi:10.1038/onc.2013.40; published online 11 March 2013
Since the publication of this article, the authors have identified two inadvertent errors in Figure 3.
First, the phosphoarray in Figure 3c listed as Kasumi-1 was a duplicate of the NOMO-1 cell line phosphoarray. The Kasumi-1 and NOMO-1 data were correctly analyzed and represented graphically in Figure 3d. A revised version of Figure 3c with images of both the Kasumi-1 and NOMO-1 phosphoarrays is shown.
In addition, it came to our attention that some panels in Figure 3e were mislabeled and one set of loading controls were shown in duplicate. In the revised version derived from the Kasumi-1 cell line, correct phospho- and total protein immunoblots and corresponding loading controls are shown.
The revised data support the conclusions originally reported in this manuscript and the text of the manuscript remains unchanged. The authors apologize for any inconvenience this may have caused.
The online version of the original article can be found at 10.1038/onc.2013.40
About this article
Cite this article
Lee-Sherick, A., Eisenman, K., Sather, S. et al. Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene 35, 6270 (2016). https://doi.org/10.1038/onc.2016.295
Cell Communication and Signaling (2021)
Molecular Therapy - Oncolytics (2020)
Journal of Thrombosis and Haemostasis (2018)
Molecular Cancer (2018)
Irf8 regulates the progression of myeloproliferative neoplasm-like syndrome via Mertk signaling in zebrafish